ISCD Learning
November 2026 - Pediatric Bone Densitometry Course
Includes a Live Web Event on 11/08/2026 at 10:00 AM (EST)
-
Register
- Non-Member - $200
- Full Member - $100
- MOC Only - $200
- Community Member - $200
- Professional Member - $200
Course Date
November 8, 2026, 10:00am - 2:00pm Eastern Time (NYC/USA)
Course Description
The Pediatric Bone Densitometry Course provides current research and best-practice techniques for the acquisition and interpretation of bone mineral density (BMD) in children and adolescents. This educational program is designed to improve learner competence in pediatric bone densitometry. By completing this course, attendees will gain conceptual and practical knowledge which can be applied in their professional practices.
Target Audience
The content is designed for healthcare providers with an interest in skeletal health assessment, including specialists, generalists and technologists working in family medicine, general and internal medicine, endocrinology, rheumatology, obstetrics/gynecology, radiology, pediatrics, physical and occupational therapy, nuclear medicine and research.
Learning Objectives
After attending the course, participants should be better prepared to:
- Recognize considerations and concerns with skeletal assessment in children and adolescents with a variety of medical conditions.
- Identify the most appropriate and reproducible sites for densitometry in children and adolescents.
- Evaluate technical aspects of bone assessment in children and adolescents.
- Describe the uses of measurement tools for acquiring bone densitometry assessments by DXA and other modalities.
- Summarize the elements to be included in a pediatric DXA report.
Method of Participation
This activity will be offered through Zoom, allowing the learner to watch and ask questions in a live format on November 8, 2026. The course will NOT be recorded for future viewing, so attendees must be present during the scheduled times. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.
Rates
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ACCME Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
This live activity is under review for accreditation by Amedco LLC targeting a maximum of 3.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation:
This activity is approved by ASRT for 4.5 Category A Continuing Education credits.
Deadline to Claim Credit
Participants will have 90 days from the live activity end date to complete the activity survey and claim continuing education credit. The last day to claim credit or access materials for this course is February 9, 2027 @ 11:00pm EST.
Schedule - Sunday, November 8th, 2026 - All times eastern (NYC/USA)
Kyla Kent, BA, CBDT
Technical Director
SAMBA Lab, Stanford University School of Medicine
Kyla Kent, BA, CBDT has been with Stanford University School of Medicine since 1991 in Adult Endocrine, Stanford Prevention Research Center and lastly as Technical Director of the Stanford Assessments of Muscle and Bone across the ages (SAMBA) Lab under the department of Pediatrics. Responsibilities include clinical facility management, protocol development, supervision of clinical staff, performance of DXA, HRpQCT, Biodex, functional strength assessments and other measures related to research conducted in the areas of childhood and adolescent bone health, bone metabolism, structural assessment, body composition, exercise, sleep, sarcopenia and healthy aging. Ms. Kent is a consultant in study design and instructor in bone density related imaging modalities for both the Palo Alto VA Hospital and Stanford Hospital, Stanford Children’s Hospital and the Stanford School of Medicine and internationally for bone mass measurement technique and analysis in growing skeletons. Ms. Kent is an active member of the International Society for Clinical Densitometry (ISCD). She joined at its beginning, did take a short hiatus and rejoined when ISCD met in San Francisco to be on the test committee. She has served on many committees over the years and currently is chair of the 2026 Tech symposium, serves on the pediatric and body composition faculties and Ask an Expert. She has served on the Facility Accreditation committee since its inception in 2011. She has acted as the Director, clinical instructor and lecturer for one of the few California certified, Limited License x-ray permit in DXA training program in Oakland, CA.
Halley Wasserman, MD, MS, CCD
Assistant Professor of Pediatrics
Cincinnati Children's Hospital Medical Center, Division of Pediatric Endocrinology
Halley Wasserman is an Associate Professor of Pediatrics in the Division of Pediatric Endocrinology at Cincinnati Children’s Hospital Medical Center where she also serves as the Director of the Metabolic Bone Disorders Clinic and Scientific Advisor for the Bionutrition and Body Composition Core Laboratory. Her clinical and research interests include optimizing care for children with disuse osteoporosis and other forms of skeletal fragility. She was the principal investigator of clinical trials assessing the effects of transdermal estrogen on bone, cognition and mental health in adolescent females with primary ovarian insufficiency and is the site PI for international disease monitoring programs for X-linked hypophosphatemia and autosomal dominant hypoparathyroidism. Dr. Wasserman has co-authored 23 original research articles and 3 invited reviews. She was a member of the 2019 ISCD Position Development Conference Pediatric Task Force.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
Pediatric Course Preparation
It is recommended, but not required, to attend our Quality Bone Densitometry Course (Clinician or Technologist) prior to attending the Pediatric Bone Densitometry course.
